# Interferon-Type-I Response and Autophagy Independently Regulate Radiation-Induced HLA-Class-I Molecule Expression in Lung Cancer

**Authors:** Erasmia T. Xanthopoulou, Ioannis Lamprou, Ioannis M. Koukourakis, Achilleas G. Mitrakas, Georgios D. Michos, Anastasia Polyzoidou, Filippos G. Antoniadis, Alexandra Giatromanolaki, Michael I. Koukourakis

PMC · DOI: 10.3390/cimb48010028 · 2025-12-25

## TL;DR

This study explores how radiation therapy affects HLA-class-I molecules in lung cancer cells through interactions with interferon-type-I responses and autophagy.

## Contribution

The study reveals that interferon-type-I and autophagy independently regulate HLA-class-I expression in lung cancer cells after radiation.

## Key findings

- Radiation therapy increases HLA-class-I expression in lung cancer cells.
- Blocking autophagy or interferon-type-I responses affects HLA-class-I levels differently.
- Interferon inhibitors have minimal impact on HLA-class-I despite reducing IFNβ and ISGs.

## Abstract

Background/Objectives: The enhancement of antitumor immune responses by radiotherapy (RT) is partially attributed to the activation of the IFN-type-I pathway. However, the loss of HLA-class-I molecules, which occurs in a large percentage of non-small-cell lung cancers (NSCLCs), may block the cytotoxic effect of T-cells and immunotherapy (IO). Moreover, autophagy is also involved in HLA downregulation. We investigated the complex interactions between RT, HLA molecules, autophagy, and IFN-type-I responses. Methods: The A549, H1299, and ATG7-deficient NSCLC cell lines, along with the modified shLC3A H1299 cell line, were used for in vitro experiments. The effect of RT (8 and 3 × 8 Gy) on Interferon beta (IFNβ), IFN-stimulated genes (ISGs), and HLA-class-I expression in combination with IFN-type-I-response inhibitors (Ruxolitinib, Tofacitinib, Amlexanox) targeting the JAK and TBK1 was studied with Flow cytometry and RT-PCR. Results: RT significantly induced HLA-class-I expression. A parallel upregulation of IFNβ and ISGs mRNA levels was also documented. Although the IFN-type-I-response inhibitors suppressed the RT-induced IFNβ and ISGs expression, their effect on HLA-class-I expression was minimal. Blockage of LC3A autophagy (shLC3A cell line) significantly upregulated HLA-class-I basal levels, and RT further enhanced HLA expression. IFN-type-I-response inhibitors blocked the RT-inductive effect in the shLC3A H1299, but had no effect in the ATG7-deficient H1650 cell line. Conclusions: The current study supports the theory that baseline autophagy, RT-induced autophagy blockage, and IFN-type-I response enhancement define the HLA-class-I levels in NSCLC cells. This complex interplay emerges as a promising target for the development of radio-vaccination strategies to enhance the efficacy of radio-immunotherapy.

## Linked entities

- **Genes:** IFNB1 (interferon beta 1) [NCBI Gene 3456], ATG7 (autophagy related 7) [NCBI Gene 10533], MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557]
- **Chemicals:** Ruxolitinib (PubChem CID 17754772), Tofacitinib (PubChem CID 9926791), Amlexanox (PubChem CID 2161)
- **Diseases:** lung cancer (MONDO:0005138)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12840286/full.md

---
Source: https://tomesphere.com/paper/PMC12840286